General Updates

19 September 2026 BSE Limited, The National Stock Exchange of India Limited, Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex, Dalal Street, Mumbai 400001, Bandra (East), Mumbai 400051, Maharashtra India Maharashtra India Scrip Code: 540975 Scrip Symbol: ASTERDM Dear Sir/Madam, Subject: Submission of Addendum to Notice of the 18th Annual General Meeting of the members of Aster DM Quality Care Limited (“Company”) In furtherance to our letter dated 4 September 2026 submitting the Notice of the 18th Annual General Meeting (“AGM”) of the members of the Company scheduled to be held on 28 September 2026, the Company has issued the enclosed Addendum to the AGM Notice to provide additional information to shareholders in relation to the explanatory statements of Item Nos. 4 and 5 of the AGM Notice. The Addendum shall be read in conjunction with, and forms an integral part of, the AGM Notice dated 5 August 2026. The above information is being provided in response to investor and stakeholder queries received in relation to the proposed capital allocation framework. Except as stated in the Addendum, all other terms, information and disclosures contained in the AGM Notice remain unchanged. This is for your information and records. This intimation is also being uploaded on Company’s website at www.asterqualitycare.com. Thank you, For Aster DM Quality Care Limited (formerly Aster DM HealthCare Limited) Hemish Purushottam Company Secretary and Compliance Officer M. No: A24331 Addendum to the Notice of the 18th Annual General Meeting of the Members of Aster DM Quality Care Limited Dear Members, This Addendum is being issued in connection with the Notice dated 5 August 2026 convening the 18th Annual General Meeting ("AGM") of the Members of Aster DM Quality Care Limited (“Company”) scheduled to be held on 28 September 2026. In addition to the disclosures contained in the Explanatory Statement to Item Nos. 4 and 5 of the AGM Notice, the Company wishes to provide the following additional information to shareholders regarding the proposed capital allocation framework contemplated under the said Items. Indicative deployment schedule The Company expects that the proposed capital allocation, intended to support investments in operating subsidiaries, joint ventures and other strategic business initiatives, may be deployed broadly in accordance with the following indicative timeline: (INR in crores) Particulars FY 2027 FY 2028 FY 2029 Expected capital allocation ~1,900 ~3,000 ~2,000 deployment schedule The above deployment schedule is indicative in nature and has been provided for the information of shareholders. Actual deployment may vary depending upon business requirements, acquisition opportunities, market conditions, regulatory approvals, funding requirements, strategic priorities and other commercial considerations prevailing from time to time. The above indicative deployment schedule applies to the proposed capital allocation under both Item No. 4 and Item No. 5 of the Notice. Save as set out in this Addendum, all other disclosures contained in the Notice and the Explanatory Statement thereto remain unchanged. The statement as aforesaid forms an integral part of the Notice dated 5 August 2026. All other contents of the Notice remain unchanged. By Order of the Board of Directors Aster DM Quality Care Limited (Formerly Aster DM Healthcare Limited) Sd/- Dr. Azad Moopen Executive Chairman DIN: 00159403